Eli Lilly
LLY
#13
Rank
ยฃ679.86 B
Marketcap
ยฃ758.39
Share price
-0.41%
Change (1 day)
17.90%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

EPS for Eli Lilly (LLY)

EPS in 2025 (TTM): ยฃ15.52

According to Eli Lilly's latest financial reports the company's current EPS (TTM) is ยฃ15.40. In 2024 the company made an earnings per share (EPS) of ยฃ8.84 an increase over its 2023 EPS that were of ยฃ4.24.

EPS history for Eli Lilly from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ15.5275.52%
2024ยฃ8.84108.52%
2023ยฃ4.24-15.84%
2022ยฃ5.0413.5%
2021ยฃ4.44-8.67%
2020ยฃ4.86-24.47%
2019ยฃ6.43176.13%
2018ยฃ2.33-1283.82%
2017-ยฃ0.20-110.57%
2016ยฃ1.8614.25%
2015ยฃ1.631.55%
2014ยฃ1.61-48.58%
2013ยฃ3.1214.25%
2012ยฃ2.73-6.63%
2011ยฃ2.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
ยฃ2.23-85.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.70-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.84-49.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.29-91.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.78-81.94%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ2.70-82.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
ยฃ1.01-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ9.78-36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.52-64.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AstraZeneca
AZN
ยฃ2.28-85.21%๐Ÿ‡ฌ๐Ÿ‡ง UK